Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)

SHA:603207 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 10, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,247	4,494	-	-	-	-
Enterprise Value	4,335	3,642	-	-	-	-
Last Close Price	32.68	26.74	-	-	-	-
PE Ratio	22.25	21.90	-	-	-	-
PS Ratio	10.96	9.47	-	-	-	-
PB Ratio	4.05	3.64	-	-	-	-
P/TBV Ratio	4.13	3.72	-	-	-	-
P/FCF Ratio	47.92	35.04	-	-	-	-
P/OCF Ratio	24.99	21.18	-	-	-	-
EV/Sales Ratio	9.05	7.68	-	-	-	-
EV/EBITDA Ratio	17.74	15.44	-	-	-	-
EV/EBIT Ratio	17.94	15.60	-	-	-	-
EV/FCF Ratio	39.59	28.40	-	-	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.01	-
Debt / EBITDA Ratio	0.00	0.01	0.00	0.00	0.01	-
Debt / FCF Ratio	0.01	0.02	0.01	0.01	0.01	-
Asset Turnover	-	0.45	0.80	1.08	1.20	1.35
Inventory Turnover	-	3.43	3.05	3.39	3.15	3.20
Quick Ratio	7.22	5.80	2.84	2.80	1.70	2.71
Current Ratio	7.60	6.14	3.42	3.64	2.10	3.35
Return on Equity (ROE)	-	22.63%	42.77%	58.25%	56.79%	78.21%
Return on Assets (ROA)	-	13.80%	24.50%	28.82%	26.63%	40.86%
Return on Capital (ROIC)	-	16.06%	30.20%	40.56%	40.03%	53.54%
Return on Capital Employed (ROCE)	18.70%	18.90%	39.70%	52.50%	62.00%	81.20%
Earnings Yield	4.06%	4.57%	-	-	-	-
FCF Yield	2.09%	2.85%	-	-	-	-
Dividend Yield	4.44%	5.61%	-	-	-	-
Payout Ratio	-	-	-	63.59%	66.97%	86.10%
Buyback Yield / Dilution	-21.00%	-12.01%	0.17%	0.22%	-	-
Total Shareholder Return	-16.56%	-6.40%	0.17%	0.22%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.